AlzeCure Pharma
1.47 SEK
-0.34 %
Less than 1K followers
ALZCUR
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-0.34 %
-21.18 %
-23.64 %
-26.50 %
-41.67 %
-37.87 %
-66.32 %
-75.84 %
-84.47 %
AlzeCure Pharma is a pharmaceutical company that researches and develops small molecule drug candidates for the treatment of diseases of the central nervous system, with a particular focus on Alzheimer's and chronic pain. The company is developing several parallel projects where the technology and research are based on its own drug platform. AlzeCure Pharma is headquartered in Huddinge, Sweden.
Read moreMarket cap
168.92M SEK
Turnover
197.35K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
5/5
2026
Interim report Q1'26
14/5
2026
General meeting '26
26/8
2026
Interim report Q2'26
All
Press releases
3rd party
ShowingAll content types
AlzeCure Pharma publishes its Annual Report for 2025
AlzeCure Pharma to present at Redeye Healthcare Day on April 14
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools